COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Orbis Medicines develops orally bioavailable macrocycle drug candidates ("nCycles") using an automated chemistry and machine-learning nGen platform to generate, synthesize, and analyze macrocycle libraries against biologic and hard-to-drug targets.
